Loading...

Loading...

Can Regulatory Speed Unlock the Global R&D Vault for Mexico?
By Hector Salinas - Fri, 11/07/2025 - 06:00
To capitalize on global R&D momentum, Mexico must ensure regulatory harmonization becomes an operationalized reality, writes Héctor Salinas.
https://mexicobusiness.news/tag/biopharma
More Health
Pfizer, Novo Nordisk Clash Over Metsera Acquisition
By Sofía Garduño - Thu, 11/06/2025 - 16:03
Pfizer and Novo Nordisk escalate legal battle over Metsera amid rising competition in the obesity treatment market.
GSK to Multiply Clinical Research Investment in Mexico
By Sofía Garduño - Thu, 11/06/2025 - 11:50
GSK plans to increase its clinical research investment in Mexico tenfold, pending regulatory improvements.
Pfizer to Acquire Metsera to Expand Obesity Portfolio
By Sofía Garduño - Mon, 09/22/2025 - 11:59
Pfizer will acquire Metsera for US$4.9 billion, expanding its pipeline of obesity and cardiometabolic treatments.
Glenmark Expands Phase 3 Study of Envafolimab to Multiple Regions
By Aura Moreno - Mon, 09/08/2025 - 09:06
Glenmark initiates a multi-country Phase 3 trial of Envafolimab in resectable Stage III non-small cell lung cancer, with enrollment starting in India.
Pfizer, PAHO Expand Vaccine Access in Latin America
By Sofía Garduño - Thu, 06/19/2025 - 09:46
Pfizer joins forces with the Pan American Health Organization (PAHO) to strengthen regional vaccine capacity throughout the region.
Marken Rebrands to Boost Global Healthcare Logistics
By Sofía Garduño - Fri, 02/21/2025 - 15:38
Marken rebrands as UPS Healthcare Precision Logistics, uniting Marken,MNX, and Polar Speed to enhance global healthcare logistics and patient access

Nipocalimab Data Shows Promise for IgG-driven Diseases: J&J
By MBN Staff - Mon, 02/17/2025 - 08:00
Johnson & Johnson’s new data on nipocalimab shows its high-affinity binding, supporting its potential for IgG-driven alloantibody diseases

BioMarin to Cut 225 Jobs in Global Reorganization
By MBN Staff - Tue, 09/03/2024 - 09:03
BioMarin cuts 225 jobs in a global reorganization after halting gene therapy developments and implementing strategic shifts.
Pfizer’s Gene Therapy Surpasses Hemophilia A Treatments
By MBN Staff - Mon, 07/29/2024 - 09:54
Pfizer’s gene therapy significantly reduces bleeding episodes in hemophilia A, showing superior results over current treatments in a late-stage trial.